无症状70%-80%颈内动脉狭窄非手术治疗的天然病程
单中心回顾性分析2003-2018年182例患者206条无症状70%-80%颈内动脉狭窄,显示狭窄进展率24.1%,无进展的同侧卒中/TIA率5.3%,5年无卒中/TIA生存率92.5%,但狭窄进展率高需密切随访。
要点
- 无症状70%-80%颈内动脉狭窄患者无进展的同侧卒中/TIA发生率低(5.3%)。
- 狭窄进展率高达24.1%,5年无进展率仅60.3%,需密切超声随访。
- 房颤和基线氯吡格雷使用与无进展卒中/TIA风险升高独立相关。
核心结论
- 无症状中度至重度颈内动脉狭窄患者无进展的同侧卒中/TIA发生率低,但狭窄进展率高,强化了密切随访的必要性。
研究设计与样本
- 单中心回顾性分析2003至2018年经双功超声诊断为无症状70%-80%颈内动脉狭窄的患者,共182例患者206条颈动脉。
主要发现
- 24.1%的狭窄出现进展;5.3%的狭窄发生无记录进展的同侧卒中/TIA,平均发生于26.4个月。
- Kaplan-Meier分析显示5年无狭窄进展率为60.3%,5年无卒中/TIA(无记录进展)率为92.5%,5年生存率为83.7%。
- 5年无进展卒中/TIA的危险因素包括房颤(HR 14.87, 95%CI 2.72-81.16; p=.002)和基线氯吡格雷使用(HR 6.19, 95%CI 1.33-28.83; p=.020)。
- 5年死亡的危险因素包括终末期肾病(HR 9.67, 95%CI 2.05-45.6; p=.004)、房颤(HR 7.55, 95%CI 2.48-23; p<.001)、头颈部放疗史(HR 6.37, 95%CI 1.39-29.31; p=.017)、非肥胖(HR 5.49, 95%CI 1.52-20; p=.009)和基线未用阿司匹林(HR 3.05, 95%CI 1.12-8.33; p=.030)。
关键数值与推荐
- 70%-80%狭窄的双功超声标准为收缩期峰值流速≥325 cm/s或颈内动脉与颈总动脉流速比≥4,且舒张末期流速<140 cm/s。
- 无症状定义为索引双功超声前6个月内无卒中/短暂性脑缺血发作(TIA)。
临床怎么用
- 对无症状70%-80%颈内动脉狭窄患者应密切超声随访以监测狭窄进展。
- 合并房颤或基线使用氯吡格雷的患者可能需更积极评估卒中/TIA风险。
局限性
- 单中心回顾性设计可能限制普遍性。
- 19条狭窄因初始接受颈动脉内膜切除术或支架置入被排除于部分分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Treatment of asymptomatic internal carotid artery (ICA) stenosis, particularly for moderate to severe (70%-80%) disease, is controversial. The goal was to assess the clinical course of patients with moderate to severe carotid stenosis. METHODS: A single institution retrospective analysis of patients with asymptomatic ICA stenosis identified on duplex ultrasound as moderate to severe (70%-80%) from 2003 to 2018 were analysed. Duplex criteria for 70%-80% stenosis was a systolic velocity of ≥325 cm/s or an ICA:common carotid artery ratio of ≥4, and an end diastolic velocity of <140 cm/s. Asymptomatic status was defined as no stroke/transient ischaemic attack (TIA) within six months of index duplex. Primary outcomes were progression of stenosis to >80%, ipsilateral stroke/TIA without documented progression, and death. RESULTS: In total, 206 carotid arteries were identified in 182 patients meeting the inclusion criteria. Mean patient age was 71.5 years, 57.7% were male, and 67% were white. There were 19 stenoses removed from analysis except for survival analysis as they initially underwent carotid endarterectomy or carotid artery stent based on surgeon/patient preference. Documented progression occurred in 24.1% of stenoses. There were 5.3% of stenoses associated with an ipsilateral stroke/TIA without documented progression, which occurred at a mean of 26.4 months. Kaplan-Meier analysis demonstrated a 60.3% five year freedom from stenosis progression, 92.5% five year freedom from stroke/TIA without documented progression, and 83.7% five year survival. Risk factors associated with stroke/TIA without documented progression at five years were atrial fibrillation (hazard ratio [HR] 14.87, 95% confidence interval [CI] 2.72-81.16; p = .002) and clopidogrel use at index duplex (HR 6.19, 95% CI 1.33-28.83; p = .020). Risk factors associated with death at five years were end stage renal disease (HR 9.67, 95% CI 2.05-45.6; p = .004), atrial fibrillation (HR 7.55, 95% CI 2.48-23; p < .001), prior head/neck radiation (HR 6.37, 95% CI 1.39-29.31; p = .017), non-obese patients (HR 5.49, 95% CI 1.52-20; p = .009), and non-aspirin use at index duplex (HR 3.05, 95% CI 1.12-8.33; p = .030). CONCLUSION: Patients with asymptomatic moderate to severe carotid stenosis had a low rate of stroke/TIA without documented progression. However, there was a high rate of stenosis progression reinforcing the need to follow these patients closely.
引用
- Cheng TW, Pointer KE, Gopal M, et al. Natural History of Non-operative Management in Asymptomatic Patients with 70%-80% Internal Carotid Artery Stenosis by Duplex Criteria. Eur J Vasc Endovasc Surg. 2020. PMID: 32660806. doi:10.1016/j.ejvs.2020.05.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。